Compugen Ltd. (CGEN)
2.13
+0.17
(+8.67%)
USD |
NASDAQ |
Nov 09, 16:00
2.13
0.00 (0.00%)
After-Hours: 19:29
Compugen Price : 2.13 for Nov. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 1.88 | 1.97 | 1.88 | 1.96 | 183992.0 |
| Nov 05, 2026 | 2.00 | 2.00 | 1.865 | 1.92 | 299932.0 |
| Nov 04, 2026 | 2.03 | 2.05 | 1.98 | 2.03 | 202920.0 |
| Nov 03, 2026 | 1.98 | 2.04 | 1.98 | 2.01 | 212669.0 |
| Nov 02, 2026 | 1.97 | 1.995 | 1.955 | 1.98 | 151473.0 |
| Oct 30, 2026 | 2.02 | 2.020 | 1.92 | 1.98 | 255458.0 |
| Oct 29, 2026 | 2.02 | 2.07 | 2.00 | 2.04 | 142900.0 |
| Oct 28, 2026 | 1.96 | 2.01 | 1.96 | 2.01 | 149269.0 |
| Oct 27, 2026 | 1.92 | 1.97 | 1.88 | 1.97 | 131409.0 |
| Oct 26, 2026 | 1.95 | 1.975 | 1.87 | 1.875 | 334469.0 |
| Oct 23, 2026 | 1.97 | 1.97 | 1.89 | 1.94 | 148021.0 |
| Oct 22, 2026 | 2.11 | 2.14 | 1.92 | 1.96 | 285546.0 |
| Oct 21, 2026 | 2.15 | 2.20 | 2.105 | 2.12 | 186970.0 |
| Oct 20, 2026 | 1.96 | 2.18 | 1.96 | 2.14 | 923299.0 |
| Oct 19, 2026 | 1.97 | 1.995 | 1.95 | 1.97 | 159252.0 |
| Oct 16, 2026 | 2.08 | 2.09 | 1.93 | 1.96 | 173435.0 |
| Oct 15, 2026 | 2.02 | 2.13 | 2.02 | 2.08 | 200141.0 |
| Oct 14, 2026 | 2.01 | 2.02 | 1.95 | 2.00 | 378142.0 |
| Oct 13, 2026 | 2.09 | 2.09 | 1.96 | 1.98 | 223637.0 |
| Oct 12, 2026 | 2.13 | 2.13 | 2.07 | 2.07 | 86473.00 |
| Oct 09, 2026 | 2.13 | 2.13 | 2.08 | 2.13 | 123364.0 |
| Oct 08, 2026 | 2.14 | 2.16 | 2.04 | 2.12 | 243152.0 |
| Oct 07, 2026 | 2.22 | 2.225 | 2.13 | 2.15 | 201813.0 |
| Oct 06, 2026 | 2.32 | 2.331 | 2.205 | 2.22 | 265380.0 |
| Oct 05, 2026 | 2.30 | 2.32 | 2.25 | 2.31 | 198865.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pluri, Inc. | 1.18 |
| Evogene Ltd. | 0.2901 |
| Scinai Immunotherapeutics Ltd. | 0.4844 |
| CollPlant Biotechnologies Ltd. | 4.11 |
| Regentis Biomaterials Ltd. | 1.26 |
Price Related Metrics
| PE Ratio | 5.749 |
| PS Ratio | 2.716 |
| Price to Book Value | 2.274 |
| Earnings Yield | 17.39% |
| Market Cap | 201.76M |
| Operating PE Ratio | 6.634 |
| Normalized PE Ratio | 5.751 |